To describe the characteristics and determinants of outcome of hospital-acquired bloodstream infection (HA-BSI) due to respiratory infection among patients admitted to intensive care units (ICUs). We performed a post hoc analysis of the EUROBACT multicenter cohort study, conducted in 162 ICUs in 24 countries. The HA-BSIs due to candidemia and from mixed respiratory and nonrespiratory sources were excluded. From the overall 1156 included in EUROBACT, 230 patients were classified as having HA-BSI respiratory infections (HA-BSI requiring ICU admission, n = 40; ICU-acquired noninvasively ventilated respiratory BSI, n = 30; and ICU-acquired invasively ventilated BSI, n = 160) and were compared with 749 patients with HA-BSI not related to respiratory infections. HA-BSI respiratory infections were more frequently due to gram negatives (76.3% vs. 56.7%, P < 0.0001), mainly Acinetobacter baumannii (18.3% vs. 10.4%, P = 0.0007), Klebsiella spp. (18.7% vs. 11%, P = 0.0013), and were less frequently because of gram-positive cocci (23.3% vs. 41.2%, P < 0.0001), with the exception of Staphylococcus aureus (11.3% vs. 9.5%, P = 0.39). HA-BSI respiratory infections were more frequently associated with multiple drug-resistant pathogens (53.9% vs. 42.7%, P = 0.0003), were more common in medical patients, and were more likely to be ICUacquired as compared with nonrespiratory infections. After adjustment for severity and other risk factors, HA-BSI of respiratory origin was a risk factor for day-28 mortality (odds ratio = 1.52 [1.02-2.27], P = 0.04).
H ospital-acquired pneumonia is the second most frequent cause of hospital-acquired infections and is associated with significant attributable morbidity and mortality, [1] [2] [3] especially when associated with bacteremia. [4] [5] [6] Respiratory infections represent the main source of hospital-acquired infections among patients admitted in intensive care units (ICUs). 5, [7] [8] [9] [10] Hospitalacquired severe sepsis and shock of respiratory origin are usually associated with a poorer prognosis when compared with other sources. 5, 6, 11, 12 Although many studies have documented the epidemiology of ventilator-associated pneumonia, little is known about hospitalacquired pneumonia that begins before invasive mechanical ventilation, requiring an admission to the ICU. This is in part because diagnostic criteria have varied according to different studies. A positive blood culture is considered as a keystone argument to accept the diagnosis of hospital-acquired pneumonia 13 when clinical and radiologic signs are present.
In the EUROBACT cohort trial, we followed episodes of hospital-acquired bloodstream infection (HA-BSI) in a large cohort of patients hospitalized in ICUs around the globe. The objectives of the present study were to describe the epidemiology of HA-BSIs due to respiratory infections treated in the ICU, comparing them with other sources of HA-BSI, and to identify the characteristics and determinants of the outcome. Furthermore, we sought to explore the determinants and outcome of HA-BSI respiratory infections categorized as those HA-BSI requiring ICU admission, and ICU-acquired HA-BSI managed with noninvasive and invasive ventilation.
METHODS
A prospective observational multicenter international cohort design was used. All participating ICUs obtained approval from their local ethics committees.
Study Protocol and Definitions
Patients were enrolled if they had a new diagnosis of HA-BSI and were admitted to an ICU. The study focused on the first episode of HA-BSI. The detailed protocol has been described previously. 14 Data collected for each patient included the dates and times of collection and of positivity of the first positive blood culture; source of infection; presence of sepsis; severity of illness; comorbidities; and infection management (source control, antimicrobial drugs, and adjunctive treatments). Severity of illness was defined at ICU admission and at HA-BSI diagnosis using simplified acute physiology score II and sequential organ failure assessment (SOFA) scores, 15 respectively. Comorbidities were assessed using the Charlson index and the 5 markers of the Chronic Health Evaluation of the APACHEII score, as reported by Knaus and colleagues. 16, 17 Clinical variables and relapses or new episodes of HA-BSI were recorded until ICU discharge, and the all-cause mortality within 28 days since first positive blood culture was ascertained. We recorded information on each ICU, including the type of hospital and of ICU, number of beds and patients, and mortality rate in the previous year (2008) .
The sources of BSI were recorded prospectively. BSI was considered to be of respiratory origin if pneumonia was clinically suspected, 13 and if the microorganism isolated in the blood culture coincided with a culture from endotracheal aspirates or other respiratory source. Episodes with multiple possible sources including the respiratory tract or without positive respiratory samples were discarded.
We defined 3 subgroups of HA-BSI of respiratory origin: (1) HA-BSI respiratory infection leading to ICU admission in a patient free from invasive mechanical ventilation when the first symptom of BSI occurred; (2) ICU-acquired HA-BSI of respiratory origin in noninvasively ventilated patients (the first symptoms of BSI occurred after ICU admission in a patient free from invasive mechanical ventilation); and (3) ICUacquired HA-BSI of respiratory origin in invasively ventilated patients (the first symptoms of BSI occurred after ICU admission in a patient still intubated or tracheostomized and mechanically ventilated).
The organisms causing HA-BSI and their antimicrobial susceptibility test results were recorded according to local policies. Candidemias were excluded. Organisms were classified as susceptible, multidrug resistant, extensively resistant, and pan-drug resistant according to the European Society of Clinical Microbiology and Infectious Diseases. 18 According to this classification scheme, bacteria other than enterococci, S. aureus, Enterobacteriaceae, and nonfermenting gram-negative bacteria were considered susceptible.
Data Management and Statistical Analysis
The data quality control check has been detailed previously. 14 The statistical analyses considered only the first episode of HA-BSI, as information was fully collected only for these occurrences. Means with SDs were used to describe normally or near-normally distributed continuous data and were compared using the t test. Medians with interquartile range were computed for skewed data and were compared using the Mann-Whitney test. Fisher exact test or the w 2 test was performed to compare categorical data.
In multivariable analyses, variables were organized into 3 tiers: country, ICU, and patient. To identify factors associated with day-28 mortality, we built a 3-tiered hierarchical logistic mixed model using the GLIMMIX procedure of the SAS software. The influence of country-based and ICU-based variables on the outcome was included through both fixed and random effects. Multilevel modeling takes into account the hierarchical structure of the data, which may manifest as intraclass correlations. To obtain a conservative estimate of the SE, a separate random-error term should be specified for each level of the analysis. 19 Therefore, to avoid overestimating the significance of risk factors for death by day 28, we took intraclass correlations into account, and we specified a separate random-error term for each tier. Variables potentially associated with day-28 mortality (P < 0.10 by univariate analysis) were introduced into the multivariable model and selected using a backward approach. Two-way clinically relevant interactions were tested in the final model. In all analyses, 2-sided P values of <0.05 were deemed statistically significant. No correction for multiple testing was performed.
RESULTS
During the study period, 1156 patients with episodes of HA-BSI associated with admission to ICU were recorded in EUROBACT. A total of 91 patients with candidemia were excluded. After exclusion of patients with concomitant pneumonia and other infectious source, 979 patients with episodes of HA-BSI remained for the overall cohort in this study (Fig. 1) . Among this group, 230 episodes were HA-BSI of exclusive respiratory origin.
The characteristics of respiratory and nonrespiratory HA-BSI are displayed in Tables 1 and 2 . HA-BSI of respiratory origin occurred more frequently in medical patients and was more likely to be diagnosed in the ICU between days 3 and 7 as compared with HA-BSI of nonrespiratory origin. HA-BSI of respiratory origin and nonrespiratory origin were associated with similar rates of septic shock and levels of SOFA score, although the respiratory component of SOFA score was higher in respiratory HA-BSIs than in other HA-BSIs.
Episodes of respiratory HA-BSI were more frequently due to gram-negative bacteria (Enterobacter spp, Klebsiella spp, Pseudomonas aeruginosa) but had similar A. baumannii rates. In contrast, nonrespiratory HA-BSIs were more frequently due to gram-positive cocci [enterococci, coagulasenegative staphylococci (CNS)] without differences in S. aureus rates (Table 3) . Extensively drug-resistant HA-BSIs were more frequent with respiratory HA-BSIs.
The crude day-28 mortality of HA-BSI of respiratory origin was higher than that of HA-BSI of nonrespiratory origin (Table 1) . When adjusted by patient characteristics and severity of the acute illness, causal microorganisms, adequacy of antimicrobial treatment, and source control, respiratory HA-BSI (odds ratio = 1.52 [1.02-2.27], P = 0.04) and abdominal HA-BSI (odds ratio = 1.63 [1.04-2.58], P = 0.035) were the 2 sources associated with the poorest outcome (Table 4) .
Very different case presentations and outcomes were observed among the 3 subgroups of HA-BSI of respiratory origin. HA-BSI of respiratory origin as the cause of ICU admission presented more often with septic shock (24/ 40 = 60%) as compared with ICU-acquired noninvasively ventilated episodes (9/30 = 30%) and invasively ventilated episodes (71/160 = 44%, P = 0.04). However, the microorganisms, resistance patterns, and time to initiation of antimicrobial treatment were not different between the 3 groups. When adjusted by center, age, chronic diseases, SOFA score, the risk of death was lower for ICU-acquired infection occurring in patients with invasive mechanical ventilation (odds ratio = 0.41 [0.19-0.92], P = 0.03) than for patients not invasively ventilated before HA-BSI of respiratory origin (Fig. 2) .
DISCUSSION
In this post hoc analysis of the EUROBACT study that involved 1156 patients with HA-BSI hospitalized in ICU, we found that respiratory infection as a source of HA-BSI was more frequently associated with gram-negative bacilli infection and with increased rates of resistant bacteria. Independently of other risk factors of death (underlying illness, severity, susceptibility profile of recovered bacteria, and appropriateness of treatment) a respiratory source was associated with a 1.5-fold increase in the day-28 mortality. Although there were significantly more resistant pathogens in HA-BSI of respiratory origin, the delay of appropriate treatment was not different between respiratory and nonrespiratory HA-BSIs. There are a number of confirmatory and novel findings in this study. We confirm previous reports that abdominal and pulmonary sources of infections are associated with a poorer prognosis. 10, [20] [21] [22] [23] This study adds important findings to the knowledge of HA-pneumonia occurring in noninvasively ventilated patients. We confirmed that pathogens responsible for HApneumonia did not differ between patients invasively ventilated and others. 13 We found that bacteremic HA-pneumonia is associated with more septic shock and a poorest prognosis when occurring in a patient without invasive ventilation as compared with bacteremic ventilator-associated pneumonia. Septic shock may have prompted ICU admission of a selected, more severe, subgroup of patients. However, the level of SOFA score when BSI occurred did not differ between the 3 groups of HA-BSI of respiratory origin. We observed that HA-pneumonia was also associated with less episodes of fever. The absence of fever has been associated with an independent increase in the risk of death in medical patients. 24 It may reflect an insufficient inflammatory reaction against infection as partly explained by the highest number of immunocompromised patients.
The increased risk of death of noninvasively ventilated, as compared with invasively ventilated HA-pneumonia is contrary to the result recently published by Esperatti et al. 13 In a prospective single-center cohort study performed in Spain, they found that noninvasive ventilation ICU-acquired pneumonia was associated with a lower mortality than ventilation acquired pneumonia (VAP). However, in this study patients with VAP were more severely ill at ICU admission as assessed by APACHEII and SOFA. The main difference between this study and ours is the accuracy of definition of HA-pneumonia. Unfortunately, in the study from Esperatti et al, 13 the rate of positive blood culture in the invasively ventilated and other patients with HA-pneumonia was not reported, making definite comparisons between both studies hazardous. It is notable that *Hierarchical logistic regression including random effects for country and centers. wEmpyema in 2 cases and lung abscesses in one case. zPatients with both respiratory and extrarespiratory source of infection were excluded from the analysis. ICU indicates intensive care unit; MDR, multiple-drugs resistant pathogen; XDR, extensively drug-resistant pathogen.
we only included patients with microbiologically documented episodes with positive blood cultures. Therefore, our results only refer to patients with bacteremic HA-pneumonia. Approximately 5% to 15% of episodes of HA-pneumonia are associated with positive blood cultures, 4 and bacteremic HApneumonia has a very distinct epidemiology. We acknowledge that the diagnosis of respiratory infections was not always based on quantitative distal samples but left at the discretion of the attending physicians in ICUs in our study. CNS causing pulmonary infection was diagnosed in 11 cases despite a questionable pathogenicity. 25 However, CNS was the only microorganism recovered in imunocompetent patients in only 7 cases. The impact of bacteremia has been studied by the European hospital-acquired pneumonia group in a cohort study involving 689 patients with hospital-acquired pneumonia hospitalized in ICU. 4 They found that bacteremic episodes represented 14.6% of episodes and were associated with a poorer prognosis (ICU mortality 57% vs. 33%, P < 0.0001), as compared with nonbacteremic HA-pneumonia. Bacteremic episodes occurred later in the hospital stay, and were associated with higher rates of methicillin-resistant S. aureus and A. baumannii etiologies. Very similar findings were observed in another case-control study involving only VAP patients. 26 The diagnosis of HA-pneumonia in noninvasively ventilated patients may have been delayed by difficulties in obtaining respiratory specimens for microbiological analysis and may explain a higher rate of septic shock and a subsequent higher risk of mortality as compared with bacteremic ventilator-associated pneumonia. The role of limitation of life support in noninvasively ventilated patients with respiratory BSI may also explain this result. However, investigators never reported an immediate decision to withdraw life-sustaining therapy in these patients.
CONCLUSIONS
The lung as a source of HA-BSI is associated with more frequent gram-negative resistant pathogens, and a poorer prognosis than nonrespiratory bacteremia. When associated with HA-BSI, lung infections occurring in noninvasively mechanical ventilated patients are more often associated with a septic shock and a poorer prognosis than bacteremic ventilatorassociated pneumonia. This may indicate a delay in appropriate diagnosis of pneumonia and treatment onset.
